STTK (Shattuck Labs Inc) Bozor qiymatining balans qiymatiga nisbati

shattucklabs.com (STTK) kompaniyasining rasmiy ramzlari

Shattuck Labs, Inc. (STTK) onkologiyaning ilg'or davolash usullarini ishlab chiqishga ixtisoslashgan. Aksiyalar narxi tendentsiyasi ARC tizimi orqali qattiq o'smalar va leykozlar uchun terapiyalarni diversifikatsiya qilishdagi muvaffaqiyatlarni aks ettiradi, joriy ko'rsatkich esa 2.77 darajasida turibdi. Tadqiqot xarajatlari va potentsial nojo'ya ta'sirlar kapitalning suyulishi bo'yicha xavotirlarni keltirib chiqarishda davom etmoqda; biroq, ishlanmalarning patentlanishi minimal ishlab chiqarish xarajatlari bilan global o'sishni ta'minlaydi.

STTK shattucklabs.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Shattuck Labs, Inc. (STTK) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi shattucklabs.com|STTK - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Shattuck Therapeutics|STTK - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Shattuck Labs|STTK - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati shattucklabs.com|STTK - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Shattuck Labs, Inc.|STTK - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati shattucklabs.com|STTK - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Shattuck Therapeutics
Kompaniyaning dastlabki tahlili:Shattuck Labs Inc - STTK
shattucklabs.com original mahsuloti

Shattuck Labs, Inc. (STTK) rivojlanishi onkologik dori vositalari uchun klinik sinovlarning muvaffaqiyati bilan bevosita bog'liqdir. Bozor qiymatining kitob kapitalizatsiyasi koeffitsiyentidagi o'zgarishlarni tahlil qilish aktivlardan yuqori bozor premiumini baholash imkonini beradi. Ushbu ko'rsatkich kompaniyaning bozor qiymatini uning sof kapitaliga bo'lib, aksiyalarning haddan tashqari qimmat baholanganlik darajasini ochib beradi. 2.77 ning joriy qiymati investorlar kutganlari va haqiqiy R&D xarajatlari o'rtasidagi muvozanatni aks ettiradi. Bu emitentning moliyaviy rezervi barqarorligini tasdiqlaydi.

Asosiy raqobatchilar

ARGX: Bozor qiymatining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Savara Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati RIGL (Rigel Pharmaceuticals Inc)|ANAB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Astria Therapeutics ATXS|engene.com (ENGN) - Balans qiymatiga nisbatan bozor qiymati|RAPT (RAPT Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Aerovate (JBIO)|Kapitallashuvning sof aktivlarga nisbati Aclaris|Bozor kapitallashuvining balans qiymatiga multiplikatori Kyverna Therapeutics, Inc KYTX|Kapitallashuvning sof aktivlarga nisbati Tiziana Life Sciences (TLSA)|CABA - Bozor kapitallashuvining balans qiymatiga multiplikatori|Ventyx Biosciences, Inc. - Kapitallashuvning sof aktivlarga nisbati|THTX - Bozor kapitallashuvining balans qiymatiga nisbati|AVTX (Avalo Therapeutics Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|ELDN (Eledon Pharmaceuticals, Inc) - Kapitallashuvning sof aktivlarga nisbati|AGEN (Agenus) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati climbbio.com (CLYM)|Zura Bio (ZURA) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ATYR (aTyr Pharma Inc)|Bozor qiymatining balans qiymatiga nisbati Adagene Inc. ADAG|Bozor qiymatining balans qiymatiga nisbati ImageneBio IMA|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|CNTB - Bozor kapitallashuvining balans qiymatiga nisbati|immunic-therapeutics.com (IMUX) - Bozor kapitallashuvining balans qiymatiga nisbati|ATRA (Atara Bio) - Bozor qiymatining balans qiymatiga nisbati|IFRX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi X4 Pharmaceuticals, Inc (XFOR)|Adicet Bio (ACET) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati celularity.com (CELU)|Bozor kapitallashuvining balans qiymatiga nisbati INMB|Barinthus Biotherapeutics PLC - Balans qiymatiga nisbatan bozor kapitallashuvi|Kezar Life Sciences, Inc (KZR) - Bozor qiymatining balans qiymatiga nisbati|SABS - Kapitallashuvning balans qiymatiga nisbati|AKTX (Akari Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Enlivex Therapeutics Ltd.|QTTB: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi GOVX|EDSA (Edesa) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation IBIO|Kapitallashuvning sof aktivlarga nisbati Carisma Therapeutics Inc. (CARM)|XTLB - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati Bolt Bio BOLT|HCWB: Bozor kapitallashuvining balans qiymatiga multiplikatori|APVO: Bozor qiymatining balans qiymatiga nisbati|AIM (aimimmuno.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc. ADTX|Sof aktivlarga nisbatan bozor kapitallashuvi gribio.com|XORTX Therapeutics (XRTX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|Indaptus Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Scinai Immunotherapeutics (SCNI)|CALI: Balans qiymatiga nisbatan bozor qiymati|AFMD (affimed.com) - Bozor qiymatining balans qiymatiga nisbati|Allakos (ALLK) - Kapitallashuvning sof aktivlarga nisbati|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IGM Bio (IGMS)|iTeos Therapeutics (ITOS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi